Preview

Ural Medical Journal

Advanced search

The role of inducing factors in the formation of Rendall plaques and the development of urolithiasis

https://doi.org/10.25694/URMJ.2018.09.12

Abstract

In this article, we present the main information about some promising markers of urolithiasis-substances formed on the surface of the transitional cell epithelium and involved in the inhibition or induction of crystal formation. The reason for their formation is still not fully understood. There is a hypothesis that they are inducers of calculus formation in the renal calyceal system and are directly related to Randall's plaques, whose role in the pathogenesis of ICDD remains a subject of discussion. In this regard, the study of the relationship of certain markers of urolithiasis with dysfunction of urothelium in the zone of formation of Randalla plaques is important for understanding the pathogenesis of this disease, for which an attempt has been made to thoroughly study Russian and English literature in databases (MEDLINE, PubMed, Medscape). A total of 126 sources were studied (all studies for the period 2000 - 2017), of which 15 publications of the most significant and relevant studies were selected for this review.

About the Authors

A. A. Kamalov
Медицинский научно-образовательный центр МГУ имени М.В. Ломоносов; МГУ имени М.В. Ломоносова
Russian Federation


D. A. Okhobotov
Медицинский научно-образовательный центр МГУ имени М.В. Ломоносов; МГУ имени М.В. Ломоносова
Russian Federation


A. N. Nizov
Медицинский научно-образовательный центр МГУ имени М.В. Ломоносов; МГУ имени М.В. Ломоносова
Russian Federation


V. K. Dzitiyev
Медицинский научно-образовательный центр МГУ имени М.В. Ломоносов; МГУ имени М.В. Ломоносова
Russian Federation


V. K. Karpov
Медицинский научно-образовательный центр МГУ имени М.В. Ломоносов; МГУ имени М.В. Ломоносова
Russian Federation


References

1. Урология: национальное руководство под ред. Н.А. Лопаткина. Москва: ГЭОТАР - Медиа. 2009; 1024с.

2. Zisman AL, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? // Kidney Int. 2015 Dec; 88(6):1240-1249;doi: 10.1038/ki.2015.254.

3. Zharikov A.Y., Motin Y.G., Zverev Y.F., Lampatov V.V., Bryukhanov V.M., Talalaeva O.S. Expression of renal crystallization inhibitors in experimental nephrolithiasis //Bull ExpBiol Med. 2012 Jun, - Vol.153, №2, -p.279-82.

4. Khan S.R. Histological aspects of the "fixed-particle" model of stone formation: animal studies // Urolithiasis. 2017Feb - Vol.45, №1, -р.75-87

5. Albert A. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease // J Enzyme Inhib. Med Chem. 2017 Dec, - Vol. 32, №1, -р.426-433.

6. Arrabal-Polo M.A., Arrabal-Martin M., Garrido-Gomez J. Calcium renal lithiasis: metabolic diagnosis and medical treatment // Sao Paulo Med J. 2013, -Vol.131, №1, -р.46-53.

7. Coe F.L., Worcester E.M. Idiopathic hypercalciuria and formation of calcium renal stones // Nat Rev Nephrol. 2016Sep, - Vol.12, № 9, -p.519-33

8. Zisman A.L., Evan A.P., Coe F.L., Worcester E.M. Do kidney stone formers have a kidney disease? // Kidney Int. 2015 Dec, - Vol.88, №6, -p.1240-1249

9. Aggarwal D., Gautam D., Sharma M., Singla S.K. Bergenin attenuates renal injury by reversing mitochondrial dysfunction in ethylene glycol induced hyperoxaluric rat model // Eur J Pharmacol. 2016 Nov 15, -№791, -р.611-621

10. Lulich J.P., Osborne C.A., Carvalho M., Nakagawa Y. Effects of a urolith prevention diet on urine compositions of glycosaminoglycans, Tamm-Horsfall glycoprotein, and nephrocalcin in cats with calcium oxalate urolithiasis //Am J Vet Res. 2012 Mar, - Vol. 73, №3, -р.447-51.

11. Kaneko K., Nishii S., Izumi Y., Yasuda M., Yamanobe T., Fukuuchi T., Yamaoka N., Horie S. Proteomic Analysis after Sequential Extraction of Matrix Proteins in Urinary Stones Composed of Calcium Oxalate Monohydrate and Calcium Oxalate Dihydrate // Anal Sci., - 2015, - Vol. 31, №9, -p.935-42.

12. Moorthy K., Krishnan M. Prediction of fragmentation of kidney stones: A statistical approach from NCCT images // Can UrolAssoc J. 2016 Jul-Aug, - Vol. 10, №7-8, -р.237-240.

13. LiX., Liu K., Pan Y., Zhang J., Lv Q., Hua L., Wang Z., Li J., Yin C. Roles of Osteopontin Gene Polymorphism (rs1126616), Osteopontin Levels in Urine and Serum, and the Risk of Urolithiasis: A Meta-Analysis //Biomed Res Int. 2015; 2015, - Vol. 315043, - p.2-10

14. Tsuji H., Shimizu N., Nozawa M., Umekawa T., Yoshimura K., De Velasco M.A., Uemura H., Khan S.R. Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition // Urolithiasis. 2014 Jun - Vol.42, №3, -р.195-202.

15. Yasui T., Okada A., Hamamoto S., Ando R., Taguchi K., Tozawa K., Kohri K. Pathophysiology-based treatment of urolithiasis //Int J Urol. 2017 Jan Vol.24, №1, - р.32- 38.


Review

For citations:


Kamalov AA, Okhobotov DA, Nizov AN, Dzitiyev VK, Karpov VK. The role of inducing factors in the formation of Rendall plaques and the development of urolithiasis. Ural Medical Journal. 2018;(9):10-13. (In Russ.) https://doi.org/10.25694/URMJ.2018.09.12

Views: 148


ISSN 2071-5943 (Print)
ISSN 2949-4389 (Online)